Follow us on...


Search News Archives
Events
«  »
SMTWTFS
 123456
78910111213
14151617181920
21222324252627
28293031 

The European Biopolymer Summit


MediSens Conference 2018


3rd International Conference on Enzymology & Molecular Biology


Forensics Europe Expo


The European Drug Safety Summit 2018


 

Media Partners


 

 


Subscibe to our YouTube channel

 

 

E-Newsletter Month  
Lab Bulletin Monthly Update December view archive
Microscopy & Image Analysis December view archive
Separation Science December view archive
Weekly Update January (3) view archive

For further information or to sign up to receive any of our E-Newsletters click here


Cell-line Derived Controls for Diagnostic Assay Development

publication date: Nov 2, 2017
 | 
author/source: AMSBIO

Cell

AMSBIO announce the addition of mutation cell line Formalin-Fixed Paraffin-Embedded (FFPE) samples and isolated genomic DNA (gDNA) controls to its extensive range of cell line reference standards.

In both routine clinical use and diagnostic assay development, biologically-relevant positive and negative controls represent an invaluable resource. To ensure accuracy and reproducibility during IVD assay development and established diagnostic tests, reference standards for genomic DNA analysis and Immunohistochemistry (IHC) assays are an essential tool. However reliable sources of reference material for rarer genetic profiles remain a constant challenge.

IsoMax™ reference standards have been accurately engineered to model the genetics of specific patient populations in vitro. These unique new reference standards can be directly incorporated into sample processing workflows for assay optimization, evaluation of sensitivity and specificity as well as monitoring the impact of workflow changes on downstream analysis.

Building on the CellMax™ range of more than 50 well-known cancer cell line FFPE controls, IsoMax™ reference standards provide a renewable source of control material for recognized mutations in cancer markers.  Based on CRISPR/Cas9 isogenic cell lines, a wide range of mutations are offered from target genes, including EGFR, KRAS, BRAF, and PIK3CA.

Available in multiple formats, including FFPE blocks, slides, scrolls, and isolate gDNA, IsoMax™ and CellMax™ standards provide an inexhaustible supply of consistent positive and negative controls.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO can draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective. Custom services include stable cell line production, CRISPR/Cas9 Genome Editing, lentivirus and adenovirus production, large scale protein production and a comprehensive portfolio of antibody services.


more about AMSBIO


more news from AMSBIO


 

 

 




Can't find what you are looking for?


Search by company, product or location

Company Name:

Location:

Product:



Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have a product enquiry, please contact the supplier directly.


Lab Bulletin is published by newleaf marketing communications ltd

Promotions